Abstract
The relative benefit of anatomic resection (AR) versus non-anatomic resection (NAR) of hepatocellular carcinoma (HCC) remains controversial. The objective of this study is to review and compare survival outcomes and recurrence rates of HCC according to tumor size and extent of resection. Data of patients with HCC who underwent curative surgical resection between January 1999 and December 2009 from Asan Medical Center were retrospectively reviewed. To compare survival outcomes between AR and NAR, propensity score matching (PSM) was conducted according to tumor size. A total of 986 patients were analyzed; 812 patients received AR and 174 patients underwent NAR. The 5-year OS rate of HCC less than 5 cm was 78.1% and 62.4% in AR and NAR, respectively (p = 0.002). The 5-year RFS rate of HCC less than 5 cm was 48.2% and 36.8% in AR and NAR, respectively (p = 0.017). The 5-year OS rate of HCC greater than or equal to 5 cm was 48.6% and 47.1% in AR and NAR, respectively (p = 0.629). The 5-year RFS rate of HCC greater than or equal to 5 cm was 30.4% and 27.5% in AR and NAR, respectively (p = 0.462). After PSM, the OS and RFS rate of HCC less than 5 cm were significantly better in the AR group. However, in HCC greater than or equal to 5 cm, there were no significant difference between the AR and the NAR group. AR in HCC less than 5 cm decreased the risk of tumor recurrence and improved OS. In HCC with diameter over 5 cm, AR and NAR showed comparable survival outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.